Clinical Trials Directory

Trials / Completed

CompletedNCT00169702

The Effect of a Weight Management Program During Treatment With Olanzapine

The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Heinrich-Heine University, Duesseldorf · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study is a prospective, randomized, open-label study.

Detailed description

The principal objective of this trial is to investigate the effect of a comprehensive behavioural treatment program on weight gain in schizophrenic patients under olanzapine treatment, and on subjective well-being.

Conditions

Interventions

TypeNameDescription
BEHAVIORALweight management program12 sessions, psychoeducation
BEHAVIORALweight management program2 weekly, 12 sessions, psychoeducational weight management

Timeline

Start date
2003-06-01
Completion
2007-07-01
First posted
2005-09-15
Last updated
2008-01-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00169702. Inclusion in this directory is not an endorsement.